DK0915880T3 - Azolotriaziner og pyrimidiner - Google Patents

Azolotriaziner og pyrimidiner

Info

Publication number: DK0915880T3
Authority: DK; Denmark
Prior art keywords: azolotriazines; pyrimidines
Prior art date: 1996-07-24

Application number

DK97936222T

Other languages

Danish (da)

English (en)

Inventor

Argyrios Georgious Arvanitis

Robert John Chorvat

Liqi He

Paul Joseph Gilligan

He Liqi

Joseph Gilligan Paul

Original Assignee

Bristol Myers Squibb Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-24

Filing date

1997-07-23

Publication date

2008-02-11

1997-07-23 Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co

2008-02-11 Application granted granted Critical

2008-02-11 Publication of DK0915880T3 publication Critical patent/DK0915880T3/da

Links

SHCRKMNTWSCEBT-UHFFFAOYSA-N N1N=NC=C2N=CC=C21 Chemical class N1N=NC=C2N=CC=C21 SHCRKMNTWSCEBT-UHFFFAOYSA-N 0.000 title 1
150000003230 pyrimidines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Virology (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Pregnancy & Childbirth (AREA)

DK97936222T 1996-07-24 1997-07-23 Azolotriaziner og pyrimidiner DK0915880T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US2329096P	1996-07-24	1996-07-24
US68604796A	1996-07-24	1996-07-24
PCT/US1997/013072 WO1998003510A1 (en)	1996-07-24	1997-07-23	Azolo triazines and pyrimidines

Publications (1)

Publication Number	Publication Date
DK0915880T3 true DK0915880T3 (da)	2008-02-11

Family

ID=26696934

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97936222T DK0915880T3 (da)	1996-07-24	1997-07-23	Azolotriaziner og pyrimidiner

Country Status (17)

Country	Link
EP (2)	EP1908764A1 (de)
KR (1)	KR100548853B1 (de)
AR (1)	AR007994A1 (de)
AT (1)	ATE375344T1 (de)
AU (1)	AU747708B2 (de)
CZ (1)	CZ2005613A3 (de)
DE (1)	DE69738197T2 (de)
DK (1)	DK0915880T3 (de)
EA (1)	EA006626B1 (de)
ES (1)	ES2294800T3 (de)
HK (1)	HK1052693A1 (de)
HU (2)	HU228962B1 (de)
LV (1)	LV12292B (de)
PT (1)	PT915880E (de)
RO (1)	RO121272B1 (de)
TW (2)	TW542827B (de)
WO (1)	WO1998003510A1 (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7094782B1 (en)	1996-07-24	2006-08-22	Bristol-Myers Squibb Company	Azolo triazines and pyrimidines
JP2001511813A (ja)	1997-02-18	2001-08-14	ニューロクラインバイオサイエンシーズ，インコーポレイテッド	Ｃｒｆレセプターアンタゴニストおよびそれらに関連する方法
EP1049699B1 (de) *	1998-01-28	2004-04-21	Bristol-Myers Squibb Pharma Company	Pyrazolotriazine als crf antagonisten
WO1999045007A1 (en) *	1998-03-06	1999-09-10	Janssen Pharmaceutica N.V.	Crf antagonistic pyrazolo[4,3-b]pyridines
US6509338B1 (en)	1998-06-22	2003-01-21	Bristol-Myers Squibb Company	Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
IL142893A0 (en)	1998-11-12	2002-04-21	Neurocrine Biosciences Inc	Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same
EP1129096B1 (de)	1998-11-12	2003-05-21	Neurocrine Biosciences, Inc.	Crf rezeptor-antagonisten und darauf bezogene methoden
WO2000059908A2 (en) *	1999-04-06	2000-10-12	Du Pont Pharmaceuticals Company	Pyrazolopyrimidines as crf antagonists
WO2000059907A2 (en) *	1999-04-06	2000-10-12	Du Pont Pharmaceuticals Company	Pyrazolotriazines as crf antagonists
US6432989B1 (en)	1999-08-27	2002-08-13	Pfizer Inc	Use of CRF antagonists to treat circadian rhythm disorders
IL148903A0 (en)	1999-09-30	2002-09-12	Neurogen Corp	Certain alkylene diamine-substituted heterocycles
JP2003510325A (ja)	1999-09-30	2003-03-18	ニューロジェン・コーポレーション	ある種のアルキレンジアミン−置換ピラゾロ［１，５−ａ］−１，５−ピリミジン及びピラゾロ［１，５−ａ］−１，３，５−トリアジン
EP1218381B1 (de) *	1999-09-30	2006-12-06	Neurogen Corporation	Amino-substituierte pyrazolo¬1,5-a\|-1,5-pyrimidine und pyrazolo¬1,5-a\|-1,3,5-triazine
CA2398956A1 (en) *	2000-02-14	2001-08-16	Japan Tobacco Inc.	A pharmaceutical composition for prophylaxis or therapy of a postoperative stress
WO2002006286A2 (en) *	2000-07-14	2002-01-24	Bristol-Myers Squibb Pharma Company	IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
AU2001275784A1 (en) *	2000-08-02	2002-02-13	Malope Company Limited	Diagnosis and treatment of non-ulcer dyspepsia based on hypothalamic-pituitary-adrenal axis abnormality
BR0208357A (pt)	2001-03-13	2004-06-29	Bristol Myers Squibb Pharma Co	Composto, composição farmacêutica, método de antagonização de um receptor de fator de liberação de corticotropina (crf), método de tratamento de disfunção, método de triagem de ligantes, método de detecção de receptores de crf, método de inibição da ligação de crf, artigo industrializado e usos do composto
CA2446980A1 (en)	2001-05-14	2002-11-21	Argyrios G. Arvanitis	Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
AU2002354575A1 (en)	2001-07-12	2003-01-29	Bristol-Myers Squibb Pharma Company	Tetrahydropurinones as corticotropin releasing factor
WO2003006015A1 (en)	2001-07-13	2003-01-23	Bristol-Myers Squibb Pharma Company	Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
US20030119831A1 (en)	2001-11-20	2003-06-26	Hartz Richard A.	3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands
AU2003217712A1 (en)	2002-03-07	2003-09-22	Smithkline Beecham Corporation	Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
KR100755577B1 (ko) *	2002-04-26	2007-09-12	일라이 릴리 앤드 캄파니	타키키닌 수용체 길항제로서의 트리아졸 유도체
FR2842809A1 (fr) *	2002-07-26	2004-01-30	Greenpharma Sas	NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
FR2850653A1 (fr) *	2003-02-04	2004-08-06	Univ Pasteur	Derives de pyrazolotriazine, procede de preparation et utilisations
US7329658B2 (en)	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7030145B2 (en)	2003-04-18	2006-04-18	Bristol-Myers Squibb Company	Pyridinyl derivatives for the treatment of depression
US7112585B2 (en)	2003-04-18	2006-09-26	Bristol-Myers Squibb Company	Pyrimidine derivatives as corticotropin releasing factor inhibitors
US7153961B2 (en)	2003-11-25	2006-12-26	Bristol-Myers Squibb Pharma Co.	Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
US7208596B2 (en)	2003-11-25	2007-04-24	Bristol-Myers Squibb Pharma Company	Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
CA2550948A1 (en)	2003-12-22	2005-07-14	Sb Pharmco Puerto Rico Inc.	Crf receptor antagonists and methods relating thereto
GB0519957D0 (en)	2005-09-30	2005-11-09	Sb Pharmco Inc	Chemical compound
JP2009502734A (ja) *	2005-07-29	2009-01-29	アステラス製薬株式会社	Ｌｃｋ阻害剤としての縮合複素環
AU2007297481B2 (en)	2006-09-20	2012-03-08	Eli Lilly And Company	Thiophene pyrazolopyrimidine compounds
EP2094709B1 (de) *	2006-09-20	2010-09-15	Eli Lilly And Company	Thiazolpyrazolopyrimidine als antagonisten des crf1-rezeptors
WO2008078091A1 (en)	2006-12-22	2008-07-03	Astex Therapeutics Limited	Bicyclic heterocyclic compounds as fgfr inhibitors
CN101679409B (zh)	2006-12-22	2014-11-26	Astex治疗学有限公司	双环杂环衍生化合物、其医药组合物和其用途
WO2008157302A2 (en) *	2007-06-13	2008-12-24	Research Development Foundation	Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling
GB0720041D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New Compounds
GB0720038D0 (en)	2007-10-12	2007-11-21	Astex Therapeutics Ltd	New compounds
GB0810902D0 (en)	2008-06-13	2008-07-23	Astex Therapeutics Ltd	New compounds
US8591943B2 (en)	2009-04-09	2013-11-26	Merck Sharp & Dohme Corp.	Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors
GB0906472D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
GB0906470D0 (en)	2009-04-15	2009-05-20	Astex Therapeutics Ltd	New compounds
EP2264035A1 (de) *	2009-06-04	2010-12-22	Merz Pharma GmbH & Co. KGaA	Glycin-B-Antagonisten
WO2012178125A1 (en)	2011-06-22	2012-12-27	Vertex Pharmaceuticals Incorporated	Compounds useful as inhibitors of atr kinase
BR112014007654A8 (pt)	2011-09-30	2018-06-12	Ipsen Pharma	Inibidores de lrrk2 quinase macrocíclicos.
GB201210686D0 (en)	2012-06-15	2012-08-01	Holsboermaschmeyer Neurochemie Gmbh	V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
US8871754B2 (en)	2012-11-19	2014-10-28	Irm Llc	Compounds and compositions for the treatment of parasitic diseases
CN105164124B (zh)	2012-11-19	2017-03-15	诺华股份有限公司	用于治疗寄生虫疾病的化合物和组合物
SI2941432T1 (en)	2012-12-07	2018-07-31	Vertex Pharmaceuticals Incorporated	2-AMINO-6-FLUORO-N- (5-FLUORO-4- (4- (4- (OXETHAN-3-YL) PIPERAZIN-1-CARBONYL) PIPERIDIN-1-YLIPRIDIN-3-YL) 1,5 ALFA) PYRIMIDINE-3-CARBOXAMIDE AS ATR KINAZE INHIBITOR
WO2014144663A1 (en)	2013-03-15	2014-09-18	The Johns Hopkins University	Methods and compositions for improving cognitive function
AU2014228512A1 (en)	2013-03-15	2015-10-01	Agenebio, Inc.	Methods and compositions for improving cognitive function
GB201310782D0 (en)	2013-06-17	2013-07-31	Max Planck Innovation Gmbh	Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
DK3077397T3 (da)	2013-12-06	2019-12-16	Vertex Pharma	2-amino-6-fluor-n-[5-fluor-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamidforbindelse anvendelig som atr-kinase-inhibitor, dens fremstilling, forskellige faste former og radiomarkerede derivater deraf
PL3152212T3 (pl)	2014-06-05	2020-06-15	Vertex Pharmaceuticals Inc.	Radioznakowane pochodne związku 2-amino-6-fluoro-n-[5-fluoro-piridyn-3-ylo]-pirazolo[1,5-a]pirymidino-3-karboksamidu przydatne jako inhibitor kinazy atr, wytwarzanie tego związku i jego różnych postaci stałych
LT3157566T (lt)	2014-06-17	2019-08-12	Vertex Pharmaceuticals Incorporated	Vėžio gydymo būdas, panaudojant chk1 ir atr inhibitorių derinį
TR201904514T4 (tr)	2014-09-17	2019-04-22	Oncodesign Sa	Makrosiklik LRRK2 kinaz inhibitörleri.
PE20170920A1 (es)	2014-11-03	2017-07-12	Bayer Pharma AG	Piperidinilpirazolopirimidinonas y utilizacion de las mismas
CA2986598C (en)	2015-05-22	2023-09-26	Agenebio, Inc.	Extended release pharmaceutical compositions of levetiracetam
HK1258570A1 (zh)	2015-09-30	2019-11-15	Vertex Pharmaceuticals Inc.	使用dna损伤剂及atr抑制剂的组合治疗癌症的方法
WO2018195397A2 (en) *	2017-04-21	2018-10-25	Kyn Therapeutics	Indole ahr inhibitors and uses thereof
CN118845788A (zh)	2017-08-14	2024-10-29	云杉生物科学公司	促肾上腺皮质激素释放因子受体拮抗剂
CA3089159A1 (en) *	2018-02-06	2019-08-15	Jiangsu Hengrui Medicine Co., Ltd.	Pyrazolo[1,5-a][1,3,5]triazine-2-amine derivative, preparation method therefor and medical use thereof
EP4438124A3 (de)	2018-04-27	2024-12-18	Spruce Biosciences, Inc.	Verfahren zur behandlung von hoden- und eierstock-nebennierentumoren
AU2019370200B2 (en)	2018-10-30	2024-12-19	Kronos Bio, Inc.	Compounds, compositions, and methods for modulating CDK9 activity
BR112023002497A2 (pt)	2020-08-12	2023-05-02	Spruce Biosciences Inc	Métodos e composições para tratamento da síndrome dos ovários policísticos
US11708372B2 (en)	2021-11-19	2023-07-25	Spruce Biosciences, Inc.	Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE786611A (fr) *	1971-08-16	1973-01-22	Int Chem & Nuclear Corp	Nouveaux inhibiteurs de xanthine-oxydase et leur procede de preparatio
US3910907A (en) *	1973-07-09	1975-10-07	Icn Pharmaceuticals	Pyrazolo(1,5-a)-1,3,5-triazines
US3995039A (en) *	1975-05-27	1976-11-30	Merck & Co., Inc.	Pyrazolo [1,5-a] [1,3,5] triazines
JPS6157587A (ja) *	1984-08-29	1986-03-24	Shionogi & Co Ltd	縮合複素環誘導体および抗潰瘍剤
US4824834A (en) *	1986-10-31	1989-04-25	Otsuka Pharmaceutical Company, Limited	Pyrazolotriazine compounds
DE3722072A1 (de) *	1987-07-01	1989-01-12	Schering Ag	6,7-dihydro-pyrazolo(1,5-a)(1,3,5) triazin-2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider und pflanzenwuchsregulierender wirkung
JP2585462B2 (ja) *	1989-10-25	1997-02-26	株式会社大塚製薬工場	ピラゾロ［１，５―ａ］ピリミジン誘導体
US5420128A (en) *	1990-10-09	1995-05-30	Otsuka Pharmaceutical Co., Ltd.	Pyrimidine derivatives, method of manufacturing the same, and androgen inhibitor
US5484760A (en) *	1990-12-31	1996-01-16	Monsanto Company	Herbicide antidotes as safeners for reducing phytotoxicity resulting from synergistic interaction between herbicides and other pesticides
KR100191774B1 (ko) *	1991-04-22	1999-06-15	오스카 아끼히꼬	피라졸로[1,5-알파] 피리미딘 유도체 및 이것을 함유하는 항염증제
US5356897A (en) *	1991-09-09	1994-10-18	Fujisawa Pharmaceutical Co., Ltd.	3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
ATE177101T1 (de) *	1992-12-17	1999-03-15	Pfizer	Pyrrolopyrimidine als crf antagonisten
US5707997A (en) *	1994-06-21	1998-01-13	Otsuka Pharmaceutical Factory, Inc.	Pyrazolo 1,5-a!pyrimidine derivative
US6020492A (en) *	1995-05-12	2000-02-01	Neurogen Corporation	Deazapurine derivatives; a new class of CRF1 specific ligands
JP3356291B2 (ja) *	1996-02-07	2002-12-16	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｃｒｆレセプター拮抗薬としてのピラゾロピリミジン類

1997
- 1997-07-23 HU HU0102187A patent/HU228962B1/hu unknown
- 1997-07-23 CZ CZ2005-613A patent/CZ2005613A3/cs unknown
- 1997-07-23 EA EA200301042A patent/EA006626B1/ru not_active IP Right Cessation
- 1997-07-23 EP EP07015514A patent/EP1908764A1/de not_active Withdrawn
- 1997-07-23 ES ES97936222T patent/ES2294800T3/es not_active Expired - Lifetime
- 1997-07-23 PT PT97936222T patent/PT915880E/pt unknown
- 1997-07-23 AU AU38942/97A patent/AU747708B2/en not_active Expired
- 1997-07-23 RO RO99-00078A patent/RO121272B1/ro unknown
- 1997-07-23 HU HU0500549A patent/HU229024B1/hu unknown
- 1997-07-23 DE DE69738197T patent/DE69738197T2/de not_active Expired - Lifetime
- 1997-07-23 KR KR1019997000568A patent/KR100548853B1/ko not_active Expired - Fee Related
- 1997-07-23 DK DK97936222T patent/DK0915880T3/da active
- 1997-07-23 WO PCT/US1997/013072 patent/WO1998003510A1/en not_active Ceased
- 1997-07-23 EP EP97936222A patent/EP0915880B1/de not_active Expired - Lifetime
- 1997-07-23 AT AT97936222T patent/ATE375344T1/de active
- 1997-07-24 AR ARP970103368A patent/AR007994A1/es unknown
- 1997-07-25 TW TW086110640A patent/TW542827B/zh not_active IP Right Cessation
- 1997-07-25 TW TW092105694A patent/TWI238164B/zh not_active IP Right Cessation
1999
- 1999-01-20 LV LVP-99-13A patent/LV12292B/en unknown
2003
- 2003-07-02 HK HK03104703.7A patent/HK1052693A1/zh unknown

Also Published As

Publication number	Publication date
TW542827B (en)	2003-07-21
ES2294800T3 (es)	2008-04-01
AR007994A1 (es)	1999-11-24
HU228962B1 (en)	2013-07-29
PT915880E (pt)	2007-12-31
TW200304916A (en)	2003-10-16
AU3894297A (en)	1998-02-10
HUP0102187A3 (en)	2002-12-28
LV12292B (en)	1999-11-20
TWI238164B (en)	2005-08-21
ATE375344T1 (de)	2007-10-15
DE69738197D1 (de)	2007-11-22
DE69738197T2 (de)	2008-07-17
EA200301042A1 (ru)	2004-02-26
EP1908764A1 (de)	2008-04-09
EA006626B1 (ru)	2006-02-24
KR100548853B1 (ko)	2006-02-02
EP0915880B1 (de)	2007-10-10
KR20000068010A (ko)	2000-11-25
CZ2005613A3 (cs)	2017-01-25
HU229024B1 (en)	2013-07-29
LV12292A (lv)	1999-06-20
RO121272B1 (ro)	2007-02-28
AU747708B2 (en)	2002-05-23
EP0915880A1 (de)	1999-05-19
WO1998003510A1 (en)	1998-01-29
HK1052693A1 (zh)	2003-09-26
HUP0102187A2 (hu)	2001-11-28
HU0500549D0 (en)	2005-08-29

Publication	Publication Date	Title
DK0915880T3 (da)	2008-02-11	Azolotriaziner og pyrimidiner
NO972236D0 (no)	1997-05-15	Dihydropyrimidiner og anvendelse derav
ID17948A (id)	1998-02-12	Piridine bersumbu heterosiklik
DK0815861T3 (da)	2002-01-21	Sulfonamider og anvendelse deraf
NO991150L (no)	1999-09-13	Pyrazolopyrimidiner og pyrazolotriaziner
DE69828963D1 (de)	2005-03-17	Wirstoffabgabe und gentherapiesystem
ID18090A (id)	1998-02-26	Mikrokapsul menggunakan iminooksadiazinadiona poliisosianat
NO983235D0 (no)	1998-07-14	Fikstur og protese innbefattende samme
DE69832657D1 (de)	2006-01-12	Empfangseinrichtungen und Empfangsverfahren
DE69836432D1 (de)	2006-12-28	Bildcoder und -decoder
BR9506832A (pt)	1997-10-14	N-pirazolilanilinas e n-pirazolilaminopiridinas
NO315610B3 (no)	2003-09-29	Azolotriaziner og -pyrimidiner
DE59706428D1 (de)	2002-03-28	Schaltungsanordnung
NO984921D0 (no)	1998-10-22	Tienopyridinderivater og deres anvendelse
PT819690E (pt)	2002-12-31	6-tienil e 4-tienil pirimidinas herbicidas
NO983556D0 (no)	1998-08-03	Formulering og anvendelse
NO976006D0 (no)	1997-12-19	Kombinert langsgående og tverrgående sporfölging
ATA185596A (de)	1998-06-15	Schmuckstück
FI972010A0 (fi)	1997-05-13	Arrangemang i en borrningsanordning
KR970007831U (ko)	1997-03-27	김밥 말이용 김발
DE59812220D1 (de)	2009-06-04	Halte- und trageband
BR7603138U (pt)	1998-09-22	Prática e única
KR970006948U (ko)	1997-02-21	학습용 시간표
FI964475A0 (fi)	1996-11-07	Kombinerat cellular- och rundradionaet
KR960036347U (ko)	1996-12-16	팔찌